{
  "main_header": {
    "sid": 1243019,
    "name": "Ambea AB",
    "stock_name": "Ambea AB",
    "full_name": "Ambea AB",
    "name_url": "stocks-analysis/ambea-ab",
    "exchange": 1025,
    "exchangecode": "OME",
    "country_id": 29,
    "currency": "SEK",
    "cmp": "131.50",
    "chg": -0.5,
    "chgp": "-0.38%",
    "dir": -1,
    "prev_price": "132.00",
    "mcapval": "10,748.14",
    "mcap": "Small Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 3365,
    "indexname": "OMX Stockholm 30",
    "isin": "SE0009663826",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "666.78 k",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/ambea-ab-1243019-1025&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Ambea AB Reports Strong Financial Performance in Pharmaceuticals Sector",
        "link": "https://www.marketsmojo.com/news/mojo-premium/ambea-ab-enters-momentum-now-strategy-due-to-strong-financial-performance-3729325",
        "imagepath": "",
        "date": "2025-11-25 15:34:15",
        "description": "<p><strong>Ambea AB</strong>, a small-cap player in the Pharmaceuticals & Biotechnology sector, has demonstrated impressive financial results for the quarter ending March 2025. The company's performance highlights its ability to navigate the market effectively, showcasing significant growth across various financial metrics.</p>\n\n<p>One of the standout figures from the latest financial report is the operating cash flow, which reached an all-time high of SEK 1,943 MM. This indicates a robust ability to generate cash from operations, a critical factor for sustaining business growth and funding future initiatives.</p>\n\n<p>Additionally, the return on capital employed (ROCE) for the half-year period has also peaked at 12.75%, reflecting efficient use of capital in generating profits. This metric is particularly important for investors as it provides insight into how well the company is utilizing its resources to ..."
      }
    ],
    "total": 1,
    "sid": "1243019",
    "stock_news_url": "https://www.marketsmojo.com/news/ambea-ab-1243019"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Ambea AB Reports Strong Financial Performance in Pharmaceuticals Sector

2025-11-25 15:34:15

Ambea AB, a small-cap player in the Pharmaceuticals & Biotechnology sector, has demonstrated impressive financial results for the quarter ending March 2025. The company's performance highlights its ability to navigate the market effectively, showcasing significant growth across various financial metrics.

One of the standout figures from the latest financial report is the operating cash flow, which reached an all-time high of SEK 1,943 MM. This indicates a robust ability to generate cash from operations, a critical factor for sustaining business growth and funding future initiatives.

Additionally, the return on capital employed (ROCE) for the half-year period has also peaked at 12.75%, reflecting efficient use of capital in generating profits. This metric is particularly important for investors as it provides insight into how well the company is utilizing its resources to ...

Read More

View All News